TA Associates Makes Majority Growth Investment in Elos Medtech
June 11, 2021
TA Associates completed a majority growth investment in Elos Medtech AB, acquiring a controlling stake via a public offer that tendered approximately 79.5% of the company’s share capital. Elos Medtech, headquartered in Gothenburg, Sweden, is a full-service contract development and manufacturing organization (CDMO) serving dental, orthopaedic and life science customers with facilities in Sweden, Denmark, China and the U.S.
- Buyers
- TA Associates, EM Intressenter AB (TA Associates acquisition vehicle)
- Targets
- Elos Medtech AB
- Sellers
- Elos Medtech shareholders
- Industry
- Medical Devices
- Location
- Västra Götaland County, Sweden
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
TA Associates Makes Strategic Growth Investment in Synokem Pharmaceuticals
January 18, 2023
Pharmaceuticals
TA Associates completed a strategic growth investment in Synokem Pharmaceuticals Ltd., with Synokem's founders remaining shareholders. The investment will support Synokem—an India-based CDMO with operations in New Delhi and manufacturing/R&D in Haridwar—to drive organic growth and pursue strategic acquisitions and capability expansion for domestic and international markets.
-
TA Associates to Make Majority Growth Investment in DL Software
February 8, 2021
Software
TA Associates has entered exclusive negotiations to make a majority growth investment in DL Software, a France-based group of 13 vertical ERP software vendors. Current majority shareholder 21 Invest France, co-investors Amundi Private Equity Funds and Swen Capital Partners, and company founders and management would retain stakes; the deal is expected to close in Q2 2021 subject to approvals.
-
Elos Medtech Acquires Klingel Medical Group from IK Partners
July 28, 2023
Medical Devices
Elos Medtech AB has agreed to acquire KLINGEL Holding GmbH (Klingel Medical Group) from IK Partners' IK VIII Fund. The acquisition expands Elos Medtech's CDMO capabilities and DACH footprint, combining Klingel's precision metal components, development services and sterile packaging expertise with Elos's global medtech platform.
-
TA Associates Makes Strategic Growth Investment in Diatech Pharmacogenetics
April 26, 2023
Biotechnology
TA Associates has signed a definitive agreement to make a strategic growth investment in Diatech Pharmacogenetics, a Jesi, Italy–based developer and manufacturer of molecular diagnostics for precision oncology. Minority investor Alto Partners will fully exit while Diatech's founder and management retain majority ownership; the capital will support product development and international expansion.
-
TA Associates Makes Growth Investment in Rocscience
January 8, 2024
Software
TA Associates completed a strategic growth investment in Rocscience, a Toronto-based developer of 2D and 3D geotechnical engineering software. The investment will support Rocscience's product and go-to-market expansion, accelerate R&D and inorganic growth initiatives; TA partners will join Rocscience's board while founder Dr. John Curran remains on the board. Financial terms were not disclosed.
-
TA Associates Makes Strategic Growth Investment in HealthMark Group
July 30, 2025
Healthcare Services
TA Associates has made a strategic growth investment in HealthMark Group, a Dallas-based provider of clinical information exchange solutions. Management and existing investor Ridgemont Equity Partners rolled meaningful stakes as TA becomes the new lead investor to accelerate HealthMark's growth, expand capabilities, and broaden market reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.